Akanksha Kaushik (A Kaushik)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 14

Top Topics

Atopic Dermatitis

Combination Therapy

Rheumatoid Arthritis Patients

Top Venues

Dermatologic therapy

Clinical and experimental dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Ankur Kumar Jindal, Sanjeev Handa, Sathish Kumar Loganathan, Murugan Sudhakar, Akanksha Kaushik, Deepti Suri, Vignesh Pandiarajan, Amit Rawat, Anju Gupta, Dipankar De, Rahul Mahajan, Surjit Singh
Juvenile localized scleroderma: A single-centre experience from India. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Dipankar De, Akanksha Kaushik, S Handa, Rahul Mahajan, Enno Schmidt
Omalizumab: an underutilized treatment option in bullous pemphigoid patients with co-morbidities. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (7) (2021)
Tarun Narang, Raihan Ashraf, Akanksha Kaushik, Sunil Dogra
Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single-centre pilot study. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (12) (2021)
Muthu Sendhil Kumaran, Vignesh Narayan, Akanksha Kaushik, Anuradha Bishnoi, Keshavamurthy Vinay, Davinder Parsad
Clinico-epidemiological profile and long term follow up in melasma. Dermatologic therapy 34 (6) (2021)
Akanksha Kaushik, Davinder Parsad, Muthu Sendhil Kumaran
Urticaria in the times of COVID-19. Dermatologic therapy 33 (6) (2020)
Akanksha Kaushik, Rahul Mahajan, Adil Karim, Sanjeev Handa, Dipankar De, Biman Saikia
Successful use of cyclosporine in epidermolysis bullosa pruriginosa. Dermatologic therapy 33 (6) (2020)
Akanksha Kaushik, Tarun Narang, Sanjeev Handa
Successful use of apremilast as a steroid-sparing agent in chronic actinic dermatitis. Dermatologic therapy 33 (6) (2020)
Akanksha Kaushik, Dinesh Raj, Debajyoti Chatterjee, Keshavamurthy Vinay
Apremilast in orofacial granulomatosis-A report of five cases. Dermatologic therapy 33 (6) (2020)
Akanksha Kaushik, Rahul Mahajan, Dipankar De, Sanjeev Handa
Paediatric morphoea: a holistic review. Part 1: epidemiology, aetiopathogenesis and clinical classification. Clinical and experimental dermatology 45 (6) (2020)
Akanksha Kaushik, Rahul Mahajan, Dipankar De, Sanjeev Handa
Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history. Clinical and experimental dermatology 45 (6) (2020)
Keshavamurthy Vinay, Akanksha Kaushik, Muthu Sendhil Kumaran, Davinder Parsad
Intravenous cyclosporine in treatment of Stevens-Johnson syndrome/toxic epidermal necrolysis: A case series. Dermatologic therapy 32 (4) (2019)
Keshavamurthy Vinay, Akanksha Kaushik, Tarun Narang, S Dogra
Ichthyosiform sarcoidosis: a mimic of leprosy? Reply from authors. Clinical and experimental dermatology 44 (5) (2019)
Tarun Narang, Akanksha Kaushik, S Dogra
Apremilast in chronic recalcitrant erythema nodosum leprosum: a report of two cases. The British journal of dermatology 182 (4) (2019)
Akanksha Kaushik, Muthu S Kumaran, Keshavamurthy Vinay, Sahil Mehta, Paramjeet Singh
Cyclosporine-induced toxic leukoencephalopathy in toxic epidermal necrolysis. International journal of dermatology 58 (2) (2018)